Chinese cancer screening firm soars 185% in Hong Kong IPO debut
Chinese cancer screening biotech firm New Horizon Health Ltd. soared 185% on its Hong Kong debut, the latest initial public…
Chinese cancer screening biotech firm New Horizon Health Ltd. soared 185% on its Hong Kong debut, the latest initial public…